Ó³»­´«Ã½

Jaime Cheah is the associate director of scientific outreach and screening in the Center for the Development of Therapeutics (CDoT) at the Ó³»­´«Ã½ of MIT and Harvard. She leads a team focused on collaborations with scientists, both at the Ó³»­´«Ã½ and across the world, to convert their bench-top research into development of patient therapies, utilizing high throughput drug screening as part of the process. She also is one of the managers of the Ó³»­´«Ã½'s Repurposing Hub and connects with a variety of researchers, including rare disease foundations, to enable access to this valuable resource.

Prior to returning to the Ó³»­´«Ã½ in 2022, Cheah served as the director of the High Throughput Sciences facility at the Koch Institute for Integrative Cancer Research at MIT for 8 years, where she oversaw a facility outfitted with state-of-the-art equipment and helped scientists design and execute their experiments in a larger, faster, and more robust way. Before that, Cheah worked as a research scientist in the chemical biology group at the Ó³»­´«Ã½ from 2010 to 2014, where she led a team of researchers on a large-scale cancer cell line profiling project, correlating the genetics of cancer to drug responses. During this time, she was one of the inaugural recipients of the Ó³»­´«Ã½'s Excellence in Management award.

Cheah holds a B.Sc. in biochemistry from McGill University and a Ph.D. in neuroscience from Johns Hopkins School of Medicine (lab of Solomon H. Snyder), and completed her post-doctoral fellowship at Novartis Institutes for BioMedical Research (NIBR - Cambridge).

Contact Jaime Cheah via email at jcheah@broadinstitute.org.